# RespireRx Pharmaceuticals Inc.: Form D filings

RespireRx Pharmaceuticals Inc., a biotechnology company in Glen Rock, NJ, filed 14 Form D notices with the SEC between 2009 and 2020. The latest, on August 12, 2020, reports $193,250 sold of a $193,250 offering to 2 investors.

Find out what RespireRx Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RespireRx%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RespireRx%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Frespirerx-pharmaceuticals-inc-849636)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RespireRx%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RespireRx%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Frespirerx-pharmaceuticals-inc-849636)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 126 VALLEY ROAD, SUITE C, Glen Rock, NJ, 07452
- Phone: (201) 444-4947
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 849636

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 12, 2020 | New notice | $193,250 | $193,250 | $0 | 2 | Jul 2, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963620000002/0000849636-20-000002-index.htm) |
| Aug 12, 2020 | New notice | $2,000,000 | $0 | $2,000,000 | 1 | Jul 28, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963620000001/0000849636-20-000001-index.htm) |
| Sep 24, 2018 | New notice | $1,500,000 | $250,750 | $1,249,250 | 10 | Sep 12, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963618000001/0000849636-18-000001-index.htm) |
| Sep 13, 2017 | New notice | $1,150,000 | $75,000 | $1,075,000 | 1 | Aug 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963617000004/0000849636-17-000004-index.htm) |
| Mar 23, 2017 | New notice | $1,500,000 | $50,000 | $1,450,000 | 1 | Mar 10, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963617000002/0000849636-17-000002-index.htm) |
| Jan 13, 2017 | New notice | $3,000,000 | $185,000 | $2,815,000 | 4 | Dec 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963617000001/0000849636-17-000001-index.htm) |
| Jan 20, 2016 | New notice | $2,500,000 | $100,000 | $2,400,000 | 1 | Jan 8, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963616000002/0000849636-16-000002-index.htm) |
| Sep 11, 2015 | New notice | $3,000,000 | $721,180 | $2,278,820 | 8 | Aug 28, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000156020815000002/0001560208-15-000002-index.htm) |
| Nov 17, 2014 | New notice | $1,000,000 | $238,500 | $761,500 | 7 | Nov 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963614000004/0000849636-14-000004-index.htm) |
| Apr 2, 2014 | New notice | $1,500,000 | $753,220 | $746,780 | 18 | Mar 18, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000084963614000002/0000849636-14-000002-index.htm) |
| Aug 22, 2012 | New notice | $3,832,214 | $3,832,214 | $0 | 13 | Aug 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000118143112046840/0001181431-12-046840-index.htm) |
| Oct 27, 2011 | New notice | $675,057 | $675,057 | $0 | 1 | Oct 20, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000118143111053650/0001181431-11-053650-index.htm) |
| Jan 22, 2010 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Jan 15, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000118143110004318/0001181431-10-004318-index.htm) |
| Aug 13, 2009 | New notice | $5,886,291 | $5,886,291 | $0 | 1 | Jul 31, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/849636/000118143109039202/0001181431-09-039202-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard E. Purcell | Executive Officer |  |
| Arnold S. Lippa | Executive Officer, Director |  |
| Kathryn E. MacFarlane | Director |  |
| Jeff E. Margolis | Executive Officer, Director |  |
| Timothy E. Jones | Executive Officer, Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Aug 10, 2020](https://specstream.ai/data/form-d/week/2020-08-10) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RespireRx Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).